Review Article
Japanese Encephalitis Virus Generated Neurovirulence, Antigenicity, and Host Immune Responses
Table 1
Suppressive effects of different JE viral proteins/antigens, its neurovirulence, and host immune responses.
| Type of protein | Virus type | Neurovirulence | Protection | Proposed mechanism | References |
| NS and S | YFV | High | mAbs | Passive immunization | [10] | NS1/NS3 | JEV | High | mAbs | Passive immunization | [9] | NS4/NS2B-3 proteinase | YFV | Mild | mAbs | Cross-neutralizing antibodies | [3, 8] | NS gp48 | 17 D YFV, DNV | High | mAbs | Passive and active immunization | [11, 14] | DNA 4S | Rec vaccinia virus | High | mAbs | Passive immunization | [12] | E or NS1 | JEV | High | mAbs | Protective immunity | [13] | NS1 | JEV | High | — | Elicits DNA immunization | [17] | M protein mutant | VSV | Low | mAbs | Passive immunization | [25] |
| | | Infection | Treatment/proposed mechanism | References |
| Cell mediated immune response | | | | NS and S | JEV | High | CTL recognition of virus | [61] | | | | Action of NK/cytotoxic T cell | [62] | | | | JEV-specific murine CD8+ cytotoxic T lymphocytes | [70, 72] | NS and S | JEV and other viruses | High | Passive transfer of immune spleen T cells | [73] | | | | MyD88 adaptor molecule-dependent/independent pathways | [94] | Virus protein | JEV and other viruses | High | JEV Th1 and Th2 cytokines | [55] | | | | Anti-inflammatory cytokine | [83, 86] | | | | Interleukin-10, endogenous IL-10 production | [89, 90] | | | | Natural antibodies and complement | [58, 60] |
| Humoral immune response to JEV | | | | NS1 protein | JEV, DNV | High | Protective immunity | [102] | NS1 | JEV | High | DNA immunization with NS1 elicits protective immunity | [103] | | | | Virus-specific cytolytic antibodies | [104] | | | | ADCC-dependent cytolysis of virus | [104] | prM and E proteins | JEV | High | Subviral particle mAbs are highly protective | [110, 114] | SMP* virus-vaccinia recombinants | | High | Induce high levels of protection against JEV | [111] | Chimpanzee fabs | JEV | High | Humanized monoclonal antibodies | [112] | Other mechanisms | | | | | | | | Antiviral actions of interferon | [132] | | | | RNA interference | [115, 118] | | | | RNA silencing | [116, 119] | | | | Complement mediated cytolysis pathway | [127] | | | | T-cell priming | [122, 123] |
|
|
Structural membrane proteins.
|